פאנדי 25 יח'מל (פקטור 8) ישראל - עברית - Ministry of Health

פאנדי 25 יח'מל (פקטור 8)

medici medical ltd, israel - factor viii (human) - אבקה להכנת תמיסה לזריקה - factor viii (human) 250 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a .fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

פאנדי 50 יח'מל ( פקטור 8 ) ישראל - עברית - Ministry of Health

פאנדי 50 יח'מל ( פקטור 8 )

medici medical ltd, israel - factor viii (human) - אבקה להכנת תמיסה לזריקה - factor viii (human) 500 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

פאנדי 100 יח'מל ( פקטור 8) ישראל - עברית - Ministry of Health

פאנדי 100 יח'מל ( פקטור 8)

medici medical ltd, israel - factor viii (human) - אבקה להכנת תמיסה לזריקה - factor viii (human) 1000 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

פאנדי 100 יח'מל  1500 יח' (פקטור 8) ישראל - עברית - Ministry of Health

פאנדי 100 יח'מל 1500 יח' (פקטור 8)

medici medical ltd, israel - factor viii (human) - אבקה להכנת תמיסה לזריקה - factor viii (human) 1500 iu/dose - factor viii inhibitor bypassing activity - factor viii inhibitor bypassing activity - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

זובירקס טבליות מסיסות 800 מג ישראל - עברית - Ministry of Health

זובירקס טבליות מסיסות 800 מג

glaxo smith kline (israel) ltd - aciclovir - טבליות ניתנות לפיזור - aciclovir 800 mg - aciclovir - aciclovir - for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. for the prophylaxis of herpes simplex infections in immune-compromised patients. for the treatment of herpes zoster infections . for the treatment of chickenpox in the following groups: 1. non-pregnant patients over 13 years-of-age who are otherwise healthy. 2. children over 12 months of age with a chronic cutaneous or pulmonary condition, or receiving long-term salicylate therapy. 3. children receiving short or intermittent courses of aerosolized corticosteroids.

אציקלו-וי 200 ישראל - עברית - Ministry of Health

אציקלו-וי 200

cts chemical industries ltd, israel - aciclovir - טבליה - aciclovir 200 mg - aciclovir - aciclovir - treatment of herpes simplex, infections of skin and mucous membranes including initial and recurrent genital herpes. suppression of recurrent herpes simplex infections. prophylaxis of herpes simplex infections in immune compromised patients. treatment of herpes zoster infections. for the treatment of chickenpox in certain groups at increased risk of severe varicella or its complications. these groups are as follows: patients over 13 years of age who are otherwise healthy. children over 12 months of age with chronic cutaneous or pulmonary condition, or receiving long term salicylate therapy. children receiving short or intermittent courses of aerosolized corticosteroids. the drug should not be taken if more than 24 hours passed from the onset of a typical chickenpox rash.

אציקלו-וי 400 ישראל - עברית - Ministry of Health

אציקלו-וי 400

cts chemical industries ltd, israel - aciclovir - טבליה - aciclovir 400 mg - aciclovir - aciclovir - treatment of herpes simplex, infections of skin and mucous membranes including initial and recurrent genital herpes. suppression of recurrent herpes simplex infections. prophylaxis of herpes simplex infections in immune compromised patients. treatment of herpes zoster infections. for the treatment of chickenpox in certain groups at increased risk of severe varicella or its complications. these groups are as follows: patients over 13 years of age who are otherwise healthy. children over 12 months of age with chronic cutaneous or pulmonary condition, or receiving long term salicylate therapy. children receiving short or intermittent courses of aerosolized corticosteroids. the drug should not be taken if more than 24 hours have passed from the onset of a typical chickenpox rash.

פלבוגאמה % 5 דיפ ישראל - עברית - Ministry of Health

פלבוגאמה % 5 דיפ

medici medical ltd, israel - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 0.5 g / 10 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy in: primary immunodeficiency syndromes such as:- congenital agammaglobulinaemia and hypogammaglobulinaemia- common variable immunodeficiency- severe combined immunodeficiency- wiskott aldrich syndromemyeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.children with congenital aids and recurrent infections.immunomodulation :idiopathic thrombocytopenic purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.guillain barr? syndrome.kawasaki disease.allogeneic bone marrow transplantation

וניקה ישראל - עברית - Ministry of Health

וניקה

medison pharma ltd - eflornithine as hydrochloride monohydrate - קרם - eflornithine as hydrochloride monohydrate 11.5 %w/w - eflornithine - eflornithine - vaniqa is indicated for the reduction of unwanted facial hair in women.

מווקס תמיסה ישראל - עברית - Ministry of Health

מווקס תמיסה

vitamed pharmaceutical industries ltd - bromhexine hydrochloride - תמיסה - bromhexine hydrochloride 2.00 mg/ml - bromhexine - bromhexine - bronchial mucolytic. it can also be given by inhalation as an aerosol solution.